|
Sally D. Bolmer joined HGS in February 2000 as Vice President Regulatory Affairs. In December 2002 Dr. Bolmer was promoted to Senior Vice President. She joined HGS from Centocor Inc. where she held several positions most recently Executive Director Worldwide Regulatory Affairs. In that position Dr. Bolmer had overall responsibility for developing and implementing Centocor's worldwide regulatory strategies for cardiovascular products. These responsibilities included overseeing the preclinical clinical and manufacturing submissions for investigational new drugs and product licensing applications for biological and gene therapy products as well as preparation and maintenance of submissions for single and multi-product facilities. Dr. Bolmer joined Centocor from Mount Sinai Medical Center New York City where she was Assistant Research Professor of Pathology. Previously she was a Post-Doctoral Associate at Massachusetts Institute of Technology. Dr. Bolmer earned a Ph.D. in Biological Chemistry from Pennsylvania State University and an Sc.B. in Biochemistry from Brown University. Dr. Bolmer is a member of the Regulatory Affairs Professional Society. | 